期刊文献+

HPLC/MS法测定人全血中的雷米芬太尼 被引量:1

Determination of remifentanil concentration in human whole blood by HPLC/MS
暂未订购
导出
摘要 目的建立全血中雷米芬太尼的高效液相色谱/质谱(HPLC/MS)测定方法,并测定围麻醉期患者体内雷米芬太尼的血药浓度。方法全血样品用1-氯丁烷进行提取,以50%甲醇含乙酸铵(20mmol/L)为流动相,色谱柱为SunfireTMC-18柱(2.1mm×150mm,5μm),流速0.3ml/min。质谱采用电喷雾电离(ESI)方式,正离子采集,以选择离子(SIR)方式进行定量,检测离子为雷米芬太尼377。结果芬太尼在0.5~70.0ng/ml浓度范围内呈良好的线性(r=0.9995)。日内、日间精密度均在15%以内,提取回收率大于82.3%,方法回收率在97.62%~100.58%。结论HPLC/MS方法灵敏、准确,适合雷米芬太尼的体内药物浓度测定。 Objective To establish a HPLC/MS method for the determination of blood remifentanil concentration. Methods The blood samples extracted with 1-chlorobutane were separated over an Sunfire^TM C-18 column (2.1 mm× 150 mm, 5μm) and the mobile phase consisted of a mixture of 50% mathanol containing ammonium acetate in concentration of 20 mmol/L. The flow rate was 0.3 ml/min. ESI+, and SIR were used for quantification. The selected ions were 377 for remifentanil. Results The calibration linear range of blood remifentanil concentrations was 0.5-70 ng/ml (r= 0. 9995). The between-day and within-day RSD% as less than 15 %. The extraction recoveries were more than 82.3% and the method recoveries were between 97.62% and 100. 58%. Conclusion HPLC/MS method is rapid, sensitive and reliable for monitoring blood remifentanil concentration.
出处 《江苏医药》 CAS CSCD 北大核心 2007年第7期718-720,共3页 Jiangsu Medical Journal
关键词 雷米芬太尼 高效液相色谱/质谱 Remifentanil HPLC/MS
  • 相关文献

参考文献8

  • 1盛娅仪,徐振邦.瑞芬太尼的药理学和临床应用[J].中国新药与临床杂志,2001,20(2):142-146. 被引量:446
  • 2丁洁,范圣登,卜晓萱,李敏,沈志忠.雷米芬太尼复合丙泊酚麻醉在上腹部手术病人的应用[J].江苏医药,2005,31(9):659-661. 被引量:1
  • 3单国瑾,吴新民,贡素宣,刘虎威,耿志宇.高效液相色谱法测定人全血中瑞芬太尼浓度[J].中国医院药学杂志,2004,24(2):67-68. 被引量:16
  • 4Haidar SH,Liang Z,Selinger K,et al.Determination of remifentanil,an ultra-short-acting opioid anesthetic,in rat blood by high performance liquid chromatography with ultraviolet detection[J].J Pharm Biomed Anal,1996,14(9):1727-1732.6
  • 5Bender J,Elshout J,Eelinger K,et al.Determinationof remifentanil in human heparinised whole blood by tandem mass spectrometry with short-column separation[J].J Pharm Biomed Anal,1999,21(3):559-567.
  • 6Grosse CM,Davis IM,Arrendale RF,et al.Determination of remifentanil in human blood by liquid-liquid extration and capillary GC-HRMS-SIM using a deuterated internal standard[J].J Pharm Biomed Anal,1994,12(2):195-203.
  • 7张现化,张弨,张利萍,翟所迪.HPLC/MS/MS联用技术测定全血中的瑞芬太尼[J].中国新药杂志,2006,15(2):137-141. 被引量:2
  • 8BjorkstenAR,ChenC,CrankshawDP.Determinationof remifentanil in human blood by capillary gas chromatography with nitrogen-selective detection[J].J Chromatogr B,2002,775(1):97-101.

二级参考文献17

  • 1耿志宇,许幸.瑞芬太尼的临床药理学[J].国外医学(麻醉学与复苏分册),2004,25(4):203-206. 被引量:208
  • 2曾慎健.艾司洛尔的临床应用[J].新药与临床,1989,8(3):152-154. 被引量:3
  • 3KABBAJ M, VARIN F. Simultaneous solid-phase extraction combined with liquid chromatography with ultraviolet absorbance detection for the determination of remifentanil and its metabolite in dog plasma [J]. J Chromatogr B, 2003, 783(1):103 -111.
  • 4HAlDER SH, LIANG ZM, SELINGER K, et al, Determination of remifentanil, an ultra-short-acting opiod anesthetic, in rat blood by high performance liquid chromatography with wutraviolet detection [J]. J Pharm Biomed Anal, 1996, 14(12) :1727-1732.
  • 5BJORKSTEN AR, CHAN C, CRANKSHAW DP. Determination of remifentanil in human blood by capillary gas chromatography with nitrogen-selective detection [ J]. J Chromatogr B, 2002, 775(1) :97-101.
  • 6BENDER J, ELSHOUT J, SELINGER K, et al. Determination of remifentanil in human heparinised whole blood by tandem mass spectrometry with short-column separation [ J ] . J Pharm Biomed Anal,1999, 21(3): 559-567.
  • 7GROSSE CM, DAVIS IM, ARRENDALE RF, et al. Determination of remifentanil in human blood by liquid-liquid extraction and capillary GC-HRMS-SIM using a denterated internal standard [J].J Pharm Biomed Anal, 1994, 12 (2) : 195 - 203.
  • 8Glass P S,Anesth Analg,1999年,89卷,S7页
  • 9Kan R E,Anesthesiology,1998年,88卷,1467页
  • 10曹慎健,新药与临床,1989年,8卷,152页

共引文献460

同被引文献4

  • 1Westmoreland CL, Hoke JF, Sebel PS, et al. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GR90291) in patients undergoing elective surgery [ J ]. Anesthesiology, 1993, 79 : 893 - 903.
  • 2Kabbaj M, Varin F. Simultaneous solid -phase extraction combined with liquidchromatography with ultraviolet absorbance detection for thedetermination of remifentanil and its metabolite in dog plasma [J]. J Chroma B, 2003(783) :103 - 111.
  • 3Hoke JF, Shlugman D, Dershwitz M, et al. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers[ J]. Anesthesiology, 1997, 87:533-41.
  • 4Dahaba AA, Oettl K, von Klobucar F, et al. End stage renal failure reduces central clearance and prolongs the elimination half life of remifentanil [ J ]. Can J Anaesth, 2002,49:369 - 374.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部